People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Healthtech, Other Health Care, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Livongo Health, Inc. | — | Healthtech | Series D+ | $227.0M | $2.7B | 2017 |
| Lightship Inc. | — | Other Health Care | Series B | $86.2M | $122.5M | 2019 |
| Soda Health, Inc. | — | Healthtech | Series C | $84.1M | $419.1M | 2024 |
| DexCare, Inc. | — | Other Health Care | Series C | $67.2M | $512.1M | 2021 |
| Folx Health, Inc. | — | Healthtech | Series B | $59.3M | $355.7M | 2020 |
| Asset Blue Pharmacy Services, Inc. | — | Biotech / Pharma | Series B | $48.0M | $104.7M | 2024 |
| MedArrive Inc. | — | Other Health Care | Series B | $40.8M | $76.7M | 2022 |
Lynne Chou O'Keefe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lynne Chou O'Keefe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Agneta Breitenstein | 2 | 2 |
| Samir Kaul | 1 | 32 |
| William Sullivan | 1 | 13 |
| Glen Tullman | 1 | 12 |
| Alon Krashinsky | 1 | 6 |
| Benjamin Robbins | 1 | 5 |
| David Schulte | 1 | 4 |
| Aaron Martin | 1 | 4 |
| Hemant J. Taneja | 1 | 3 |
| THOMAS PIKE | 1 | 3 |
| Derek Streat | 1 | 3 |
| JOSEPH E. CAREY | 1 | 2 |
| Inna Plumb | 1 | 2 |
| Daniel Trigub | 1 | 2 |
| Brian Vandenberg | 1 | 2 |
| Morgan Cheatham | 1 | 2 |
| Anna J. Baird | 1 | 1 |
| Lee J. Shapiro | 1 | 1 |
| Tom J. Main | 1 | 1 |
| MARIO E. CHRISTOPHER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.